Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Neuroblastoma 2Small Cell Lung Carcinoma 1Sarcoma 1Retinoblastoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Medulloblastoma 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Gallbladder Neoplasms 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Colorectal Neoplasms 1Colonic Neoplasms 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Burkitt Lymphoma 1Breast Neoplasms, Male 1Breast Neoplasms 1Bile Duct Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 4Cisplatin 4Vincristine 3Methotrexate 3Carboplatin 3Temozolomide 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Filgrastim 2Etoposide 2sargramostim 1becatecarin 1aldesleukin 1Vinblastine 1Topotecan 1Thiotepa 1Paclitaxel 1Nivolumab 1Mental Status and Dementia Tests 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Induction Chemotherapy 1Ginkgo biloba extract 1FANG vaccine 1Erlotinib Hydrochloride 1Donepezil 1Cyproheptadine 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Choroid Plexus Neoplasms × becatecarin × Clear all
NCT00006102 2013-02-05

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
200 enrolled
CNSLymphoidOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Lymphoma, Medulloblastoma, Neuroblastoma, Oligodendroglioma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡